BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/9/2025 7:51:33 AM | Browse: 11 | Download: 0
Publication Name World Journal of Transplantation
Manuscript ID 111959
Country United Kingdom
Category Transplantation
Manuscript Type Retrospective Cohort Study
Article Title Outcomes of basiliximab vs alemtuzumab induction in kidney allograft recipients with matched immunological Profiles: A retrospective cohort study
Manuscript Source Unsolicited Manuscript
All Author List Chukwuma A Chukwu, Philip A Kalra, Marcus Lowe, Kay Poulton, Titus Augustine and Anirudh Rao
Funding Agency and Grant Number
Corresponding Author Chukwuma A Chukwu, Consultant, PhD, Department of Nephrology, Liverpool University Hospitals NHS Foundation Trust, Mount Vernon Street, Liverpool L7 8YE, Mersey Side, United Kingdom. chukwuma.chukwu@rlbuht.nhs.uk
Key Words Kidney transplantation; Immunosuppression induction; Alemtuzumab; Basiliximab; Graft outcomes
Core Tip This retrospective cohort study compared real-world outcomes of alemtuzumab and basiliximab induction in kidney transplant recipients from two tertiary centers in North-West England, one routinely using alemtuzumab and the other exclusively basiliximab. Using propensity score matching to reduce confounding, we evaluated graft function, graft and patient survival, acute rejection, infection, and other long-term complications. Alemtuzumab induction was found to be associated with lower estimated glomerular filtration rate, and higher risks of cytomegalovirus and BK viremia, post-transplant malignancy, and death-censored graft loss compared with basiliximab. These findings emphasize the need for individualized selection of induction therapy, balancing the potent immunosuppressive effects of alemtuzumab against its potential for adverse outcomes, and support tailored approaches based on recipient risk profile and center-specific experience.
Citation Chukwu CA, Kalra PA, Lowe M, Poulton K, Augustine T, Rao A. Outcomes of basiliximab vs alemtuzumab induction in kidney allograft recipients with matched immunological Profiles: A retrospective cohort study. World J Transplant 2025; In press
Received
2025-07-15 23:19
Peer-Review Started
2025-07-15 23:20
First Decision by Editorial Office Director
2025-08-05 08:57
Return for Revision
2025-08-05 08:57
Revised
2025-10-09 17:26
Publication Fee Transferred
2025-10-13 16:49
Second Decision by Editor
2025-12-09 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-09 07:51
Articles in Press
2025-12-09 07:51
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com